The impact of Medicare Part D on pharmaceutical R&D
By: Margaret E. Blume-Kohout, Neeraj Sood.
Contributors: Sood, Neeraj.; National Bureau of Economic Research.
Series: NBER working paper series -- working paper 13857
Publisher: National Bureau of Economic Research
Published: 2008
Place of publication: Cambridge, Massachusetts
Language: eng
Format: Electronic resource
Description: "Recent evidence suggests that Medicare Part D has increased prescription drug use among the elderly, and earlier studies have indicated that increasing market size induces pharmaceutical innovation.  This paper assesses the impact of Medicare Part D on pharmaceutical research and development (R&D), using time-series data on the number of drugs in preclinical and clinical development by therapeutic class.  We demonstrate that the passage of Medicare Part D was associated with significant increases in pharmaceutical R&D, especially for classes with high elderly market share"--National Bureau of Economic Research web site.
Notes: Title from PDF file as viewed on 6/16/2008.

Includes bibliographical references.

Also available in print.

System requirements: Adobe Acrobat Reader.

Mode of access: World Wide Web.